P3 Health Partners Inc (PIII): Next-Year EPS Estimate 64.54%
As of 2026-07-17, P3 Health Partners Inc (PIII) has a next-year EPS growth estimate of 64.54%.
On 2026-05-24, analyst consensus for PIII's next-year EPS growth shifted from 92.33% to 64.54% — a negative change of 27.79 percentage points. The revised estimate has been sustained across 41 subsequent trading sessions. Current-year growth is projected at 81.34%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- EPS growth next year
- 64.54%
- EPS growth this year
- 81.34%
- EPS next quarter (est)
- -$1.90
- Last price
- $10.82
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-17 | 64.54% | 81.34% | -$1.90 | $10.82 |
| 2026-07-16 | 64.54% | 81.34% | -$1.90 | $11.11 |
| 2026-07-15 | 64.54% | 81.34% | -$1.90 | $10.21 |
| 2026-07-14 | 64.54% | 81.34% | -$1.90 | $10.43 |
| 2026-07-13 | 64.54% | 81.34% | -$1.90 | $10.47 |
| 2026-07-12 | 64.54% | 81.34% | -$1.90 | $9.80 |
| 2026-07-09 | 64.54% | 81.34% | -$1.90 | $9.86 |
| 2026-07-08 | 64.54% | 81.34% | -$1.90 | $10.09 |
| 2026-07-07 | 64.54% | 81.34% | -$1.90 | $10.53 |
| 2026-07-06 | 64.54% | 81.34% | -$1.90 | $10.29 |
| 2026-07-05 | 64.54% | 81.34% | -$1.90 | $11.37 |
| 2026-07-02 | 64.54% | 81.34% | -$1.90 | $11.37 |
| 2026-07-01 | 64.54% | 81.34% | -$1.90 | $11.07 |
| 2026-06-30 | 64.54% | 81.34% | -$1.90 | $10.80 |
| 2026-06-29 | 64.54% | 81.34% | -$1.90 | $11.94 |
| 2026-06-28 | 64.54% | 81.34% | -$1.90 | $11.31 |
| 2026-06-25 | 64.54% | 81.34% | -$1.90 | $10.68 |
| 2026-06-24 | 64.54% | 81.34% | -$1.90 | $11.14 |
| 2026-06-23 | 64.54% | 81.34% | -$1.90 | $11.99 |
| 2026-06-22 | 64.54% | 81.34% | -$1.90 | $11.31 |
| 2026-06-21 | 64.54% | 81.34% | -$1.90 | $10.75 |
| 2026-06-18 | 64.54% | 81.34% | -$1.90 | $10.75 |
| 2026-06-17 | 64.54% | 81.34% | -$1.90 | $11.23 |
| 2026-06-16 | 64.54% | 81.34% | -$1.90 | $11.35 |
| 2026-06-15 | 64.54% | 81.34% | -$1.90 | $11.69 |
| 2026-06-14 | 64.54% | 81.34% | -$1.90 | $12.23 |
| 2026-06-11 | 64.54% | 81.34% | -$1.90 | $13.56 |
| 2026-06-10 | 64.54% | 81.34% | -$1.90 | $13.54 |
| 2026-06-09 | 64.54% | 81.34% | -$1.90 | $12.54 |
| 2026-06-08 | 64.54% | 81.34% | -$1.90 | $12.25 |
Recent News
- P3 Health Partners Inc. Q1 2026 Earnings Call SummaryMoby
- P3 Health Partners Inc (PIII) Q1 2026 Earnings Call Highlights: Surpassing Expectations and ...GuruFocus.com
- P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference CallBusiness Wire
- P3 Health Partners Announces Fourth Quarter and Full Year 2025 ResultsBusiness Wire
- P3 Health Partners Inc (PIII) Q4 2025: Everything You Need To Know Ahead Of EarningsGuruFocus.com
Screen Performance
Aggregate stats across all 1864 tickers our top-EPS-revision screen has flagged over the past 107 days.
- Median return since detection
- +2.5%
- % of tickers in the green
- 55%
- Median return on winners
- +20.8%
- Large revisions captured
- 1048
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is P3 Health Partners Inc's next-year EPS growth estimate?▾
As of 2026-07-17, P3 Health Partners Inc (PIII) has a next-year EPS growth estimate of 64.54%, based on analyst consensus.
When was the latest EPS estimate revision for PIII?▾
The most recent revision occurred on 2026-05-24, when analysts adjusted the next-year EPS growth estimate from 92.33% to 64.54%.
What sector and industry does P3 Health Partners Inc belong to?▾
P3 Health Partners Inc operates in the Healthcare sector, specifically the Medical Care Facilities industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PIII appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. P3 Health Partners Inc (PIII) appears here because it was detected by our daily top-EPS-revision-performer screen.